Navigation Links
First fruitful, then futile: Ammonites or the boon and bane of many offspring
Date:4/23/2012

For 300 million years, they were the ultimate survivors. They successfully negotiated three mass extinctions, only to die out eventually at the end of the Cretaceous along with the dinosaurs: Ammonoids, or ammonites as they are also known, were marine cephalopods believed to be related to today's squid and nautiloids. Ammonoids changed their reproductive strategy early on in the course of evolution. However, what was once a successful initial strategy may well have proved to be a fatal boomerang at the end of the Cretaceous, as an international team of researchers headed by paleontologists from the University of Zurich demonstrate in a study recently published in the science journal Evolution.

Embryos already had coiled shells

At the beginning of their evolution, ammonoids had straighter shells, which, like other mollusks, they began to coil during the Devonian Period. The precise reason behind this change is unknown. The selection pressure in favor of more tightly coiled shells is believed to have sprung from the ammonoids' natural predators. As the scientists have now discovered, the shell change also affected the ammonoid embryos. "In the oldest ammonoids, the embryonic shells were considerably bigger and coiled less tightly than in later forms," explains Kenneth De Baets, a paleontologist at the University of Zurich, summing up the latest findings.

Smaller hatchlings, more offspring

There were two more evolutionary trends that coincided with the increasingly more tightly coiled shells: The size of the embryonic shells shrank increasingly over time the hatchlings became smaller and smaller. In parallel, the shell size of fully grown animals increased and, on the whole, the animals became increasingly bigger. Based on this, the researchers deduced that the number of offspring in ammonoids rocketed during the Devonian Period. This is confirmed by discoveries of substantial clusters of fossilized embryonic shel
'/>"/>

Contact: Kenneth Da Baets
kenneth.debaeats@pim.uzh.ch
41-446-342-347
University of Zurich
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Putting plants online: 4 leading botanical gardens to create first online catalog of all plants
2. ORNL microscopy yields first proof of ferroelectricity in simplest amino acid
3. First description of a triple DNA helix in a vacuum
4. Scientists complete first-ever emperor penguin count from space
5. First mass extinction linked to marine anoxia
6. New technology tracks sparrow migration for first time from California to Alaska
7. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
8. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
9. First complete full genetic map of promising energy crop
10. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
11. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First fruitful, then futile: Ammonites or the boon and bane of many offspring
(Date:7/25/2014)... a pleiotropic factor characterized by the existence of ... that confer to the protein deeply different characteristics. ... myelination occurring during development and the different phases ... degeneration, axon regrowth, remyelination and target reinnervation, Researchers ... that the soluble NRG1 upregulation observed in Schwann ...
(Date:7/25/2014)... of a molecular testing panel developed at UPMC ... initial surgery for patients with thyroid nodules and ... Cancer Institute (UPCI), partner with UPMC CancerCenter., The ... and other diagnostic testing agencies, improved the chances ... 30 percent, according to the study published this ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
... , AMIA, the association for professionals in biomedical and ... the National Coordinator on Health Information Technology (DHHS/ ONCHIT), ... meaningful use of electronic health records (EHRs) over the ... Policy Committee (HITPC), on the continuation of support for ...
... When patients receive a bone marrow transplant, they are getting ... are needed when a patient is low on red blood ... be caused by cancer or even cancer treatments such as ... transplant might not succeed because the transplanted stem cells don,t ...
... Spanish . Fernando Rendo, biologist at the ... with the intention of completing the genealogical tree ... Country Autonomous Community (CAPVEAE) and Navarre. Concretely, he opted for ... (a kind of variation in the DNA sequence) that can ...
Cached Biology News:AMIA on meaningful use: Invest in people and technology 2How long do stem cells live? 2Basque thesis investigates wide diversity within certain ovine, bovine and equine breeds 2Basque thesis investigates wide diversity within certain ovine, bovine and equine breeds 3
(Date:7/25/2014)... A new study by researchers from the University ... tiny nanosystems function, unlocking the potential to create ... study, which has been published in the prestigious ... a novel laser technique to examine in rich ... a small cluster containing an acetylene molecule and ...
(Date:7/25/2014)... WABC Radio show out of New York City, ... will be hosting California-based Vet-Stem, Inc.’s Founder and CEO, Robert ... pets. Dr. Harman first visited the show in November ... pets suffering from osteoarthritis and other degenerative diseases, as well ... , Young has invited Dr. Harman back to dial down ...
(Date:7/25/2014)... 25, 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: ... the development and commercialization of a once-daily, oral therapy ... today announced financial results for the period ended June ... , Reported cash and cash equivalents totaling $37.4 ... December 31, 2013.  , Reported a net loss ...
(Date:7/25/2014)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... announced that it will release its unaudited financial results for ... on Thursday, August 14, 2014 EDT. The Company will host ... August 15, 2014, at 8:00 a.m. EDT (Friday, August 15, ... Company,s financial results and provide an update on recent corporate ...
Breaking Biology Technology:Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 2Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2
... Researchers Comprise One of the Main User Groups of febit,s ... Simplified and Automated Microarray Technology, MEDFORD, Mass., ... it will introduce the Geniom RT Analyzer(R) to,the U.S. market ... in Boston., RNA-researchers, one of the main user groups ...
... SANTA CLARA, Calif., April 22 /PRNewswire/,-- Agendia BV, ... of molecular,diagnostics, and Agilent Technologies, Inc. (NYSE: ... to collaborate to develop new in-vitro,diagnostic tests. In ... Agendia products will continue to be supplied on ...
... SUPG ), a pharmaceutical company dedicated to the discovery, ... malignancies, invites all interested parties to listen and,view a ... at 9:30 a.m. ET,(6:30 a.m. PT) to approximately 12:00 ... Investors and interested parties may access the webcast ...
Cached Biology Technology:febit to Introduce Geniom RT Analyzer(R) to U.S. Market at RNAi World Congress 2febit to Introduce Geniom RT Analyzer(R) to U.S. Market at RNAi World Congress 3Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement 2Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement 3
MitoScreen (JC-1) Kit , 100 tests Consult technical datasheet for details....
Large-fragment, single-stranded carrier DNA of the highest quality, perfectly suited for all types of yeast transformation....
... , Customer Peptide Synthesis , 20 Amino Acid length ... 20 mg will return to customer for future usage conjugation ... , Maintenance 102 days/each , ... x5 /each , Test bleed (app. 5 ml) ...
Request Info...
Biology Products: